iifl-logo-icon 1

Indo US Bio-Tech Ltd Share Price

214
(0.56%)
Jul 16, 2024|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open215
  • Day's High220
  • 52 Wk High303.95
  • Prev. Close212.8
  • Day's Low212
  • 52 Wk Low137.5
  • Turnover (lac)18.19
  • P/E51.94
  • Face Value10
  • Book Value31.29
  • EPS4.12
  • Mkt. Cap (Cr.)429.11
  • Div. Yield0
No Records Found

Indo US Bio-Tech Ltd KEY RATIOS

Sector

Miscellaneous

Open

215

Prev. Close

212.8

Turnover(Lac.)

18.19

Day's High

220

Day's Low

212

52 Week's High

303.95

52 Week's Low

137.5

Book Value

31.29

Face Value

10

Mkt Cap (₹ Cr.)

429.11

P/E

51.94

EPS

4.12

Divi. Yield

0

Indo US Bio-Tech Ltd Corporate Action

9 Sep 2023

12:00 AM

AGM

Announcement Date: 09 Sep, 2023

arrow

17 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

21 Sep 2023

12:00 AM

BookCloser

arrow

21 Aug 2023

12:00 AM

Bonus

arrow

Indo US Bio-Tech Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Indo US Bio-Tech Ltd SHAREHOLDING SNAPSHOT

18 Jul, 2024|04:49 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 70.17%

Foreign: 0.00%

Indian: 70.17%

Non-Promoter- 29.82%

Institutions: 0.00%

Non-Institutions: 29.82%

Custodian: 0.00%

Share Price

Indo US Bio-Tech Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

10.03

9.17

6.07

6.07

Preference Capital

0

0

0

0

Reserves

44.47

29.71

15.47

10.37

Net Worth

54.5

38.88

21.54

16.44

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2019

Revenue

50.05

40.08

39.76

35.34

yoy growth (%)

24.86

0.81

12.48

20.05

Raw materials

9.03

-0.13

-5.15

-22.19

As % of sales

18.04

0.34

12.97

62.79

Employee costs

-0.71

-0.52

-0.57

-0.58

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2019

Profit before tax

5.48

4.12

2.87

2.81

Depreciation

-0.43

-0.26

-0.22

-0.25

Tax paid

-0.25

0.97

-0.32

-0.72

Working capital

15.68

5.33

4.9

8.03

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2019

Growth matrix (%)

Revenue growth

24.86

0.81

12.48

20.05

Op profit growth

25.5

38.6

15.82

26.6

EBIT growth

25.95

40.82

17.19

16.12

Net profit growth

2.73

101.12

21.37

44.1

View Ratios
Particulars (Rupees in Crores.)Mar-2022Mar-2021Mar-2020

Gross Sales

50.06

40.11

39.76

Excise Duty

0

0

0

Net Sales

50.06

40.11

39.76

Other Operating Income

0

0

0

Other Income

0.18

0.04

0.01

Indo US Bio-Tech Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Godrej Agrovet Ltd

GODREJAGRO

853.45

45.7616,408.4936.441.171,486.97117.5

Indegene Ltd

INDGN

573.35

99.5413,718.4848.90272.571.66

Thomas Cook (India) Ltd

THOMASCOOK

251.15

118.4711,818.8417.160.24284.9539.36

RattanIndia Enterprises Ltd

RTNINDIA

78.49

21.2110,849.43-80.7402.016.86

CMS Info Systems Ltd

CMSINFO

529.95

24.358,625.59111.311.09580.71116.06

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Indo US Bio-Tech Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

Jagdish Ajudia

Whole-time Director

Maltiben Ajudia

Executive Director

Priyanka Ajudia

Non-Exec. & Independent Dir.

Ritaben Nileshbhai Kikani

Company Secretary

Dimpy Joshi

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Indo Us Bio-Tech Limited was originally incorporated as a Private Limited Company with the name Pollucid Bio-Tech Private Limited at Junagadh on February 4, 2004. Subsequently, the name was change to Pellucid Bio-Tech Private Limited on January 5, 2005. Later on, the name of the Company was changed to Indo Us Bio-Tech Private Limited on March 9, 2007. Consequently, upon conversion into Public Limited Company, the name of the Company was changed to Indo Us Bio-Tech Limited on January 11, 2018. The Company is an ISO 9001-2008 company, involved in crop research & development throw breeding, production of seeds, processing, packing and marketing of high performing hybrid and open pollinated varieties of agricultural crops. The Company has its seed processing plants located in Gujarat, where the seeds are processed, stored and packed with the help of modern machineries. In addition to own processing plant, the Company is also hiring custom seed processing and storage facilities in various states to enable proper supply of seeds in time. Currently Indo US Bio-Tech LTD is one of the fastest growing seed company in India with a large network of over 2500+ distributors and dealers spread across the country.The Company started its journey way back in 2004, having its own laboratory for seed testing at Junagadh. In laboratory, the company used to test the proportion of Enzyme-Linked Immunosorbent Assay (ELISA) available in the seeds. ELISA tests are primarily used for the detection of p
Read More

Company FAQs

What is the Indo US Bio-Tech Ltd share price today?

Down Arrow

The Indo US Bio-Tech Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹214 today.

What is the Market Cap of Indo US Bio-Tech Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Indo US Bio-Tech Ltd is ₹429.11 Cr. as of 16 Jul ‘24

What is the PE and PB ratio of Indo US Bio-Tech Ltd?

Down Arrow

The PE and PB ratios of Indo US Bio-Tech Ltd is 51.94 and 6.84 as of 16 Jul ‘24

What is the 52 Week High and Low of Indo US Bio-Tech Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Indo US Bio-Tech Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Indo US Bio-Tech Ltd is ₹137.5 and ₹303.95 as of 16 Jul ‘24

What is the CAGR of Indo US Bio-Tech Ltd?

Down Arrow

Indo US Bio-Tech Ltd's CAGR for 5 Years at 41.21%, 3 Years at 105.72%, 1 Year at 38.15%, 6 Month at -12.65%, 3 Month at -2.75% and 1 Month at -8.84%.

What is the shareholding pattern of Indo US Bio-Tech Ltd?

Down Arrow

The shareholding pattern of Indo US Bio-Tech Ltd is as follows:
Promoters - 70.17 %
Institutions - 0.00 %
Public - 29.83 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.